Navigation Links
Insmed Provides Update on Follow-On Biologics and IPLEX(TM) Programs
Date:4/29/2008

egative market trends, our entrance into the follow on biologics market may be unsuccessful, our common stock could be delisted from the Nasdaq Capital Market and other risks and challenges detailed in our filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K for the year ended December 31, 2007. Readers are cautioned not to place undue reliance on any forward-looking statements which speak only as of the date of this release. We undertake no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances that occur after the date of this release or to reflect the occurrence of unanticipated events.

Investor Relations Contact:

Brian Ritchie - FD

212-850-5683

brian.ritchie@fd.com

Corporate Communications Contact:

John Procter - Gibraltar Associates

202-879-5808

jprocter@gibraltar-llc.com


'/>"/>
SOURCE Insmed Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Insmed Receives FDA Orphan Drug Designation for IPLEX(TM) in the Treatment of Myotonic Muscular Dystrophy
2. Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis
3. Insmed Launches National Awareness Campaign Surrounding Follow-On Biologics
4. Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R)
5. CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs
6. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
7. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
8. Raptor Pharmaceuticals Provides Update of Product Programs
9. Monogram Provides Update on Trofile(TM) Co-Receptor Tropism Assay
10. Arbios Provides Clinical Strategy for SEPET(TM) Pivotal Trial
11. Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2008)...lif., Nov. 20 Bionovo, I...present results from the Phase 1B,clinical trial ...ic breast,cancer, BZL101, at the Society for Inte... in Atlanta, Georgia. The Company,s oral presenta...ill be presented as a part of the Best of the,SIO...
(Date:11/20/2008)...rway, November 20 The Scandinavian...as announced results of studies on its,lead antim...Washington, DC,the studies showed that the novel...cidal effect, significantly better towards killing... than marketed gold standard drugs. In,addition t...
(Date:11/19/2008)...N.Y., Nov. 19 Biotech scientists i...toxicology research to better understand the effec...systems, reports Genetic Engineering & Biotec...ted in figuring out a new compound,s mechanism of ...cology technique, according to the November 15 iss...
(Date:11/18/2008)...Nov. 18 Arlington Medical Resource...e for the pharmaceutical and diagnostic,imaging i...ing,s Privigen was,sold in the U.S. during the th... of intravenous immune globulin (IVIG) and was lau...duct created from the blood plasma of thousands,o...
Breaking Medicine Technology:Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5Lytix Presents LTX-109 Anti-Microbial Data at ICAAC 2GEN Reports on the Trend Toward Predictive Toxicogenomics 2Over $10 Million of CSL Behring's Privigen Was Sold in the U.S. During the Third Quarter of 2008 2CryoCath to present at Piper Jaffray and BMO Healthcare conferences 6960 1CryoCath to present at Piper Jaffray and BMO Healthcare conferences 6960 2Environmental Tectonics Corporations Sterilization Systems Group Announces New Contracts 6957 1Environmental Tectonics Corporations Sterilization Systems Group Announces New Contracts 6957 2Environmental Tectonics Corporations Sterilization Systems Group Announces New Contracts 6957 3Xenome Enters Into Joint Research Collaboration to Discover Novel Peptide Therapeutics with Amylin Pharmaceuticals 6955 1Xenome Enters Into Joint Research Collaboration to Discover Novel Peptide Therapeutics with Amylin Pharmaceuticals 6955 2Sosei Announces Update on Phase I Trials for SD118 6953 1Sosei Announces Update on Phase I Trials for SD118 6953 2Sosei Announces Update on Phase I Trials for SD118 6953 3
(Date:11/21/2008)...abor , , FRIDAY, Nov. 21 (HealthDay News... activates the uterine muscles for contraction dur...es for preterm labor. , The molecule prostacyc...f these uterine muscle cells, keeping them relativ...rs from Dartmouth Medical School in New Hampshire,...
(Date:11/21/2008)...anuary 8, 2009 , , TORONTO, Nov. 21 /PRNews...edEmerg") (OTCBB: MDER), one of Canada,s leading p...it has obtained an interim order from the Ontario ...y announced plan of arrangement (the "Arrangement"...will acquire all of MedEmerg,s outstanding shares....
(Date:11/21/2008)...Health Science Center at Houston will launch a new...XAS), to promote geriatrics training for physician...Donald W. Reynolds Foundation and $1.25 million in...riatric medicine principles to everyone from the m...s. With the reach of Lyndon B. Johnson General Hos...
(Date:11/21/2008)... -- Heska Corporation,(Nasdaq: HSKA ) today ann...,Security Analysts, 12th Annual Biotech and Specia... Avenue of the Americas, 2nd Floor in New York, NY...a.m. Eastern Time (7:35 a.m.,Mountain Time) and w...s,following the presentation through a link under...
Breaking Medicine News(10 mins):Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 2Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 3Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 2Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 3Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 4
... Hospital doctors warn that children playing footb... from blisters caused by football boots // . Acco... toxic shock syndrome in the UK have been attribut...in children. However if misdiagnosed or left untre...
...ch is already running in a loss would have to pay ...s they are not in a position // to fulfil the comm...tem for the health services. The trusts in the so...d 50 full-time employees to help develop the ?20bn...
...radesh has decided to take action against erring P...has now fixed the number of patients //to be treat...y health centres so as to stop the 'popular' pract...eave the hospital early, at least an hour before t...
...as announced at the Cheltenham Science Festival th... mount Everest to conduct //a research into the ef...cientists from the Centre for Aviation, Space and ...nstitute of Human Health and Performance, Universi...
Other Medicine News:Health News:Budding Footballers at Risk from Blood Infection 2Health News:Already Short Staffed And In Deficit NHS Fails To Supply Staff For IT Project 2Health News:UP Government Fixes Work Schedules for Provincial Medical Service Doctors 2Health News:Mount Everest to be Site of Research into Hypoxia 2
Since 1991 Intersurgical Incorporated manufactures high efficiency breathing filters, heat and moisture exchangers, ventilator circuits, oxygen therapy products, hand-held nebulizers and an extensive
...The Ulti-Mist™ HME product line has the righ...to adults and from intubated patients to patients ...humidification for both anesthesia and critical ca...ers provide maximum protection for patients and st...
...These hygroscopic condenser humidifiers (HCH) capt...turn them in the inspired gas. Small and compact, ...ic and hygroscopic benefits. Depending on the tida...small-volume model., ,The adult HCH is ideal for ...
...These hygroscopic condenser humidifiers (HCH) capt...turn them in the inspired gas. Small and compact, ...ic and hygroscopic benefits. Depending on the tida...small-volume model., ,The adult HCH is ideal for ...
Medicine Products: